Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T-cell lymphoma: A case report.
Vincent CamusPascaline EtancelinFanny DrieuxElena-Liana VeresezanJean-Michel PicquenotDominique PentherMathieu ViennotPhilippe RuminyNathalie ContentinEmilie LemasleStéphane LeprêtreSydney DuboisJuliette PenichouxAspasia StamatoullasAlexandra ZduniakHélène LanicFabrice JardinPublished in: Clinical case reports (2023)
Peripheral T-cell lymphomas have an aggressive disease course associated with poor outcomes. We report a young patient with highly pretreated relapsed/refractory nodal follicular helper T-cell lymphoma (angioimmunoblastic-type [nTFHL-AI]), who successfully received an allogeneic stem cell transplantation following belinostat therapy. The complete hematologic response achieved has lasted more than 2 years.
Keyphrases
- stem cell transplantation
- high dose
- acute lymphoblastic leukemia
- acute myeloid leukemia
- multiple myeloma
- diffuse large b cell lymphoma
- hodgkin lymphoma
- case report
- dendritic cells
- low dose
- neoadjuvant chemotherapy
- regulatory t cells
- stem cells
- middle aged
- adipose tissue
- machine learning
- bone marrow
- radiation therapy
- smoking cessation
- locally advanced
- rectal cancer